Clinical Diagnostics include: Infectious Disease Diagnostics, IVD-Cleared Genetic Tests, Diagnostic
Reagents, Clinical Research, Clinical Instruments, and Clinical Technology.... read more
Specialties and Expertise:COVID‑19 Testing, Health Diagnostics, Coronavirus (COVID-19) Diagnostics, Respiratory Infection Diagnostics,
Bloodstream Infection Diagnostics, Gastrointestinal Infection Diagnostics, Healthcare-associated Infection Diagnostics, xMAP ... read more
ARIES SARS-CoV-2 Assay - Molecular Test
Available Contractsno information
Delivery Lead Timeno information
Contact Infono informationno information
Size and Minority Status
- Products and services 2
- Сommodity codes 26
by the FDA under Emergency Use Authorization.
ARIES SARS-CoV-2 Assay is a sample-to-answer test that detects the SARS-CoV-2 virus. It is authorized by the FDA under Emergency Use Authorization.
Luminex won BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test. Luminex received $642,450 to support development, testing, and submission for an Emergency Use Authorization (EUA) for the ARIES® SARS-CoV-2 Assay.
human serum and dipotassium EDTA plasma using Luminex 200, MAGPIX, MAGPIX NxTAG enabled, and
FLEXMAP 3D Systems. It is authorized by the FDA under EUA.
Luminex Corporation offers xMAP SARS-CoV-2 Multi-Antigen IgG Assay that detects IgG antibodies in human serum and dipotassium EDTA plasma using Luminex 200, MAGPIX, MAGPIX NxTAG enabled, and FLEXMAP 3D Systems. It is authorized by the FDA under EUA.
Development of Second, Rapid SARS-CoV-2
Test. Luminex received $642,450 to supp...
proposed technology aims at creating a simple,
low-cost and rugged cell analyzer capable of e...
Phase I project builds the foundation for a fully
automated and portable multiplex diagnostic a...
complex matrices remains one of the most
challenging problems facing biological detecti...
Existing Contracts 2
Locations Served 25
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.